This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Roche Diabetes Care, Inc.
Roche Diabetes Care, Inc., a prominent player in the diabetes management industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1896, Roche has established itself as a leader in innovative healthcare solutions, particularly in diabetes care. The company is renowned for its cutting-edge blood glucose monitoring systems, insulin delivery devices, and digital health solutions, which empower patients to manage their diabetes effectively. Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring that individuals with diabetes can easily monitor their health. With a strong market position, the company has achieved notable milestones, including the development of the Accu-Chek product line, which is widely recognised for its reliability and accuracy. Through continuous innovation and a commitment to improving patient outcomes, Roche Diabetes Care remains at the forefront of diabetes management solutions.
DitchCarbon Score
How does Roche Diabetes Care, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diabetes Care, Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diabetes Care, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting. As part of its corporate family, Roche Diabetes Care inherits emissions data and climate initiatives from Roche Holding AG. However, there are no documented reduction targets or specific climate pledges available for Roche Diabetes Care at this time. The absence of detailed emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own specific climate strategies, despite being part of a larger organisation with established commitments. Roche Holding AG, the parent company, may have its own emissions data and climate targets, which could indirectly impact Roche Diabetes Care's future commitments. As the company continues to align with its parent organisation's sustainability goals, it is expected to develop its own strategies to address carbon emissions and contribute to broader climate action efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 249,350,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 114,452,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,402,719,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Diabetes Care, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
